Bimi International Medical Inc
NASDAQ:BIMI
Relative Value
There is not enough data to reliably calculate the relative value of BIMI.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
BIMI Competitors Multiples
Bimi International Medical Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Bimi International Medical Inc
NASDAQ:BIMI
|
1.4k USD | 0 | -0 | -0 | -0 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
115.3B USD | 0.3 | 28.6 | 20.1 | 22.6 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
68.5B USD | 0.2 | 42.2 | 14.8 | 18.7 | |
| US |
|
Cencora Inc
NYSE:COR
|
70B USD | 0.2 | 43.1 | 15.1 | 19.1 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
51.9B USD | 0.2 | 31.1 | 15 | 19.5 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
34.8B AUD | 5.8 | 65.8 | 49.6 | 49.6 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.3B USD | 0.7 | 23.7 | 11.3 | 15.8 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.8B CNY | 0.2 | 11.3 | 15.2 | 15.2 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63.8B CNY | 1.5 | 17.3 | 13.3 | 13.3 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
66.1B HKD | 0.1 | 8.6 | 1.6 | 2 |